Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma

PURPOSE: Cancer development and immune escape involve DNA methylation, copy number variation, and other molecular events. However, there are remarkably few studies integrating multiomics genetic profiles into endometrial cancer (EC). This study aimed to develop a multiomics signature for the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhicheng, Wang, Qiu, Liu, Xiuqing, Zheng, Jiantong, Ji, Ling, Li, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587907/
https://www.ncbi.nlm.nih.gov/pubmed/36281289
http://dx.doi.org/10.1155/2022/8998493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587907/
https://www.ncbi.nlm.nih.gov/pubmed/36281289
http://dx.doi.org/10.1155/2022/8998493

Ejemplares similares